Business Context and Reporting Period
This Form 8-K is a current report filed by Griffin-American Healthcare REIT IV, Inc. on August 19, 2020. The registrant is an emerging growth company incorporated in Maryland. The filing serves to disclose a Regulation FD communication, specifically the issuance of the Second Quarter 2020 Investor Update Letter.
Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Exhibit 99.1 (Investor Update Letter), which is incorporated by reference but not detailed in the body of this 8-K form.
Material Changes
No material changes to financial performance or operations are explicitly detailed in the text of this filing. The document solely announces the release of the Q2 2020 investor update.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, and risk factors are referenced as being included in the Second Quarter 2020 Investor Update Letter (Exhibit 99.1). The filing explicitly states that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 for actual Q2 2020 financial results and operational updates.
- Note that the registrant has elected to use the extended transition period for complying with new or revised financial accounting standards as an emerging growth company.
- Confirm that the information in the attached investor letter is not legally "filed" under Section 18 of the Exchange Act, limiting liability exposure for the statements therein.
- Identify the Chief Executive Officer as Jeffrey T. Hanson, who signed the report.